Catalyst Wire Dossier Catalyst Wire Dossier

Leuprorelin implant (5 mg)

leuprorelin · Recordati Group
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Leuprorelin implant (5 mg), covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer

See pricing